Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C N Berry

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|December 8, 1998
Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitorsE Gandossi, C Lunven, C Gauffeny, et al.
Biochemical Pharmacology|April 15, 1984
Enzymatic inactivation of 6-keto-prostaglandin E1 in vitro: comparison with prostaglandin E1C N Berry, J R Hoult, R J Griffiths, et al.
British Journal of Pharmacology|October 17, 1998
Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosisC N Berry, C Lunven, I Lechaire, et al.
Biochemical Pharmacology|January 15, 1985
Age-dependent changes in the synthesis and catabolism of 6 oxo PGE1 and other prostanoids by the rat kidney in vitroR J Griffiths, C N Berry, J R Hoult, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Antithrombotic activity of argatroban in experimental thrombosis in the rabbitC N Berry, D Girard, C Girardot, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1985
Highly potent inhibition of prostaglandin 15-hydroxydehydrogenase in-vitro and of prostaglandin inactivation in perfused lung by the new azobenzene analogue, Ph CL 28AC N Berry, J R Hoult, J A Phillips, et al.
Thrombosis and Haemostasis|January 1, 1996
Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombinC Lunven, C Gauffeny, C Lecoffre, et al.
British Journal of Pharmacology|June 1, 1996
Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparinN Duval, C Lunven, D P O'Brien, et al.
British Journal of Pharmacology|February 1, 1986
Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lungC N Berry, R J Griffiths, J R Hoult, et al.
Arzneimittel-Forschung|May 1, 1995
Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodentJ Levrier, D Duval, M Prouteau, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|December 8, 1998
Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitorsE Gandossi, C Lunven, C Gauffeny, et al.
Biochemical Pharmacology|April 15, 1984
Enzymatic inactivation of 6-keto-prostaglandin E1 in vitro: comparison with prostaglandin E1C N Berry, J R Hoult, R J Griffiths, et al.
British Journal of Pharmacology|October 17, 1998
Antithrombotic activity of a monoclonal antibody inducing the substrate form of plasminogen activator inhibitor type 1 in rat models of venous and arterial thrombosisC N Berry, C Lunven, I Lechaire, et al.
Biochemical Pharmacology|January 15, 1985
Age-dependent changes in the synthesis and catabolism of 6 oxo PGE1 and other prostanoids by the rat kidney in vitroR J Griffiths, C N Berry, J R Hoult, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Antithrombotic activity of argatroban in experimental thrombosis in the rabbitC N Berry, D Girard, C Girardot, et al.
The Journal of Pharmacy and Pharmacology|September 1, 1985
Highly potent inhibition of prostaglandin 15-hydroxydehydrogenase in-vitro and of prostaglandin inactivation in perfused lung by the new azobenzene analogue, Ph CL 28AC N Berry, J R Hoult, J A Phillips, et al.
Thrombosis and Haemostasis|January 1, 1996
Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombinC Lunven, C Gauffeny, C Lecoffre, et al.
British Journal of Pharmacology|June 1, 1996
Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparinN Duval, C Lunven, D P O'Brien, et al.
British Journal of Pharmacology|February 1, 1986
Identification of 6-oxo-prostaglandin E1 as a naturally occurring prostanoid generated by rat lungC N Berry, R J Griffiths, J R Hoult, et al.
Arzneimittel-Forschung|May 1, 1995
Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodentJ Levrier, D Duval, M Prouteau, et al.
Pageof 3